BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 11724088)

  • 1. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.
    Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S
    Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
    Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic ketoacidosis associated with aripiprazole.
    Makhzoumi ZH; McLean LP; Lee JH; Ibe AI
    Pharmacotherapy; 2008 Sep; 28(9):1198-202. PubMed ID: 18752391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
    Vuk A; Kuzman MR; Baretic M; Osvatic MM
    Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.
    Nihalani ND; Tu X; Lamberti JS; Olson D; Olivares T; Costea GO; Tang W
    Ann Clin Psychiatry; 2007; 19(2):105-12. PubMed ID: 17612850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New onset diabetes with ketoacidosis attributed to quetiapine.
    Marlowe KF; Howard D; Chung A
    South Med J; 2007 Aug; 100(8):829-31. PubMed ID: 17713311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of clozapine on glucose metabolism.
    Yazici KM; Erbas T; Yazici AH
    Exp Clin Endocrinol Diabetes; 1998; 106(6):475-7. PubMed ID: 10079027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.
    Polcwiartek C; Kragholm K; Rohde C; Hashemi N; Vang T; Nielsen J
    Diabetologia; 2017 Sep; 60(9):1678-1690. PubMed ID: 28593353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic ketoacidosis. A rare complication of gestational diabetes.
    Maislos M; Harman-Bohem I; Weitzman S
    Diabetes Care; 1992 Aug; 15(8):968-70. PubMed ID: 1505328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes mellitus after treatment with clozapine].
    Brugman NJ; Cohen D; de Vries RH
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent.
    Hepburn K; Brzozowska MM
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27507689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes and ketoacidosis with atypical antipsychotics.
    Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
    Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoacidosis as a side-effect of clozapine: a case report.
    Kostakoğlu AE; Yazici KM; Erbaş T; Güvener N
    Acta Psychiatr Scand; 1996 Mar; 93(3):217-8. PubMed ID: 8739670
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose clozapine and diabetic ketoacidosis.
    Lafayette JM; Pirl WF; Henderson DC
    Psychosomatics; 2003; 44(3):249-52. PubMed ID: 12724507
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
    Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
    Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.